ALKERMES PLC's ticker is ALKS and the CUSIP is G01767105. A total of 274 filers reported holding ALKERMES PLC in Q4 2022. The put-call ratio across all filers is 2.58 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $8,396,225 | +7.9% | 268,250 | -2.8% | 4.58% | +15.9% |
| Q1 2023 | $7,782,808 | -22.4% | 276,084 | -28.0% | 3.95% | -25.0% |
| Q4 2022 | $10,023,050 | +8.1% | 383,584 | -7.6% | 5.27% | +8.7% |
| Q3 2022 | $9,268,000 | -25.0% | 415,055 | 0.0% | 4.85% | -11.3% |
| Q2 2022 | $12,365,000 | +20.7% | 415,055 | +6.6% | 5.47% | +40.4% |
| Q1 2022 | $10,242,000 | +3.9% | 389,267 | -8.1% | 3.90% | +3.1% |
| Q4 2021 | $9,854,000 | -28.9% | 423,660 | -5.8% | 3.78% | -26.8% |
| Q3 2021 | $13,865,000 | +25.8% | 449,600 | 0.0% | 5.16% | +36.0% |
| Q2 2021 | $11,024,000 | – | 449,600 | – | 3.79% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Woodford Investment Management Ltd | 2,639,676 | $96,322,000 | 7.78% |
| Meditor Group Ltd | 892,400 | $32,564,000 | 6.11% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 233,000 | $8,502,000 | 3.14% |
| Tamarack Advisers, LP | 140,000 | $5,109,000 | 2.03% |
| Asymmetry Capital Management, L.P. | 27,673 | $1,010,000 | 1.69% |
| First Light Asset Management, LLC | 211,164 | $7,705,000 | 1.00% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 304,992 | $11,129,000 | 0.85% |
| Nicollet Investment Management, Inc. | 28,020 | $1,022,000 | 0.67% |
| PRIMECAP MANAGEMENT CO/CA/ | 23,263,530 | $848,886,000 | 0.62% |
| Rhenman & Partners Asset Management AB | 120,399 | $4,393,000 | 0.51% |